Semaglutide users sometimes experience reduced appetite and food intake, which may lower dietary carnitine absorption
These include: Bloating and gas : Increased bacterial fermentation produces gases, causing abdominal distension and flatulence Mild abdominal discomfort or cramping : Usually resolves as the microbiome stabilises Changes in bowel habits : Temporary loose stools or, less commonly, constipation Nausea : Occasionally reported, particularly if taken on an empty stomach These symptoms typically diminish within 23 weeks of consistent use
When injected subcutaneouslytypically in the abdomen, thigh, or upper armthe medication disperses through fatty tissue and triggers an immune response
Semaglutide users experienced a 1.7% drop in HbA1c, while the liraglutide group showed a 1.0% reduction
Semaglutide weight loss may be ideal if your BMI is 30 or higher, or 27 with a weight-related condition like diabetes or hypertension